Finance

Lists
FPH:NZE
Fisher & Paykel Healthcare Corporatn Ltd
48,78 NZD
+0,16%
(+0,080) 1D
15-окт., 17:00:27 GMT+13  ·   NZD
All symbols
SymbolPriceChange% Change
Generating top insights for FPH...
Open
48,71 NZD
High
48,80 NZD
Low
48,06 NZD
Mkt. cap
28,71 млд
Avg. vol.
497,99 миң
Volume
676,53 миң
Dividend
1,07%
Quarterly dividend
0,13 NZD
Ex-dividend date
2026-ж., 22-июн.
P/E ratio
61,53
52-wk high
49,22 NZD
52-wk low
32,16 NZD
EPS
0,79 NZD
Shares outstanding
588,27 млн
No. of employees
7 миң
Open
48,71 NZD
High
48,80 NZD
Low
48,06 NZD
Mkt. cap
28,71 млд
Avg. vol.
497,99 миң
Volume
676,53 миң
Dividend
1,07%
Quarterly dividend
0,13 NZD
Ex-dividend date
2026-ж., 22-июн.
P/E ratio
61,53
52-wk high
49,22 NZD
52-wk low
32,16 NZD
EPS
0,79 NZD
Shares outstanding
588,27 млн
No. of employees
7 миң
News stories
From web sources and news partners
Profile
Fisher & Paykel Healthcare Corporation Limited is a manufacturer, designer and marketer of products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea. Based in New Zealand, their products and systems are sold in around 120 countries worldwide. FPH is primarily an exporting company, with just 1 percent of revenue coming from New Zealand sales. Wikipedia
About Fisher & Paykel Healthcare Corporatn Ltd
CEOLewis G. Gradon
Employees7,4 миң
Founded1934
HeadquartersОкленд, Auckland, Жаӊы Зеландия
SectorMedical device
Previous reportsAll values in NZD
Loading Previous Earnings...
Revenue
Net income
All values in NZD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
544,25 млн
544,25 млн
609,95 млн
609,95 млн
Cost of goods sold
201,40 млн
201,40 млн
217,75 млн
217,75 млн
Cost of revenue
201,40 млн
201,40 млн
217,75 млн
217,75 млн
Research and development expenses
57,05 млн
57,05 млн
60,70 млн
60,70 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
142,75 млн
142,75 млн
156,35 млн
156,35 млн
Operating expense
199,80 млн
199,80 млн
217,05 млн
217,05 млн
Total operating expenses
401,20 млн
401,20 млн
434,80 млн
434,80 млн
Operating income
143,05 млн
143,05 млн
175,15 млн
175,15 млн
Other non operating income
-
-
-
-
EBT including unusual items
141,90 млн
141,90 млн
173,85 млн
173,85 млн
EBT excluding unusual items
141,90 млн
141,90 млн
173,85 млн
173,85 млн
Income tax expense
35,40 млн
35,40 млн
46,10 млн
46,10 млн
Effective tax rate
24,95%
24,95%
26,52%
26,52%
Other operating expenses
-
-
-
-
Net income
106,50 млн
106,50 млн
127,75 млн
127,75 млн
Net profit margin
19,57%
19,57%
20,94%
20,94%
Earnings per share
-
-
-
-
Interest and investment income
2,05 млн
2,05 млн
2,05 млн
2,05 млн
Interest expense
-2,75 млн
-2,75 млн
-2,40 млн
-2,40 млн
Net interest expenses
-700,00 миң
-700,00 миң
-350,00 миң
-350,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
174,95 млн
174,95 млн
204,75 млн
204,75 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору